News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Rubrik's ARR is growing about 33% year-over-year to roughly $1.66 billion.
  • The company reports high gross margins.
  • Free cash flow is positive and accelerating.
  • Shares trade at an elevated price-to-sales of about 13.5.
  • Analyst recommends a tactical long with specified entry, stop and target over a 180-trading-day horizon.
  • Thesis highlights improving unit economics as the primary catalyst for upside.
  • Trade plan explicitly lists catalysts and includes stop-loss risk controls.

Latest Articles

Gevo: A Clear Path for EBITDA Upside — Buy at the Breakout

Gevo: A Clear Path for EBITDA Upside — Buy at the Breakout

Gevo looks positioned to convert recent non-dilutive cash events and improving operating leverage into a step-change in EBITDA. With a market cap near $386M and enterprise value of $475M, shares are pricing in slow progress; proof points from tax-credit monetization, carbon credit sales and a favorable SAF market could re-rate the stock. This is a …

The XFLT Proxy Contest: What XFLT Shareholders Need to Know

The XFLT Proxy Contest: What XFLT Shareholders Need to Know

XAI Floating Rate & Alternative Income Trust (XFLT) announced a shareholder vote on July 30, 2026, to approve a new sub-advisory agreement with Rockford Tower Asset Management, a King Street Capital Management subsidiary. This change follows termination of previous sub-adviser Octagon due to significant underperformance. The Board anticipates impro…

Bempikibart Momentum: A Tactical Long on Q32 Bio (QTTB)

Bempikibart Momentum: A Tactical Long on Q32 Bio (QTTB)

Q32 Bio's recent program developments and corporate actions have shifted the risk profile from pure early-stage binary to one with tangible commercial optionality and cash support. I outline a mid-term trade plan that captures upside to program re-rating while limiting downside with a defined stop.

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

SL Science Holding Limited announced successful presentation of preclinical data demonstrating the potent anti-glioblastoma effects of their novel gamma delta T-cell therapy at the 2026 World Congress of Basic and Clinical Pharmacology. The research, conducted in collaboration with Taipei Medical University, JY BioMed, and HeXun Biosciences, showed…

Nano Dimension Continues Execution of Cost Savings Initiatives

Nano Dimension Continues Execution of Cost Savings Initiatives

Nano Dimension Ltd. announced the termination of its corporate headquarters lease, originally set to expire in 2031, resulting in approximately $25 million net cash savings after lease termination payment. This move is part of broader cost-saving initiatives following the sale of MarkForged, aiming to strengthen the company's financial position by …

General Fusion to Ring Nasdaq Opening Bell Today, July 17, 2026

General Fusion to Ring Nasdaq Opening Bell Today, July 17, 2026

General Fusion Group Ltd. announced its recent listing on Nasdaq under the ticker GFUZ and its celebration ringing the Nasdaq Opening Bell, marking it as the first publicly listed fusion energy company. The company highlighted its Magnetized Target Fusion (MTF) technology and the development of its LM26 fusion demonstration machine, aiming to achie…

NANO Nuclear Energy Joins Virginia Nuclear Energy Consortium to Advance Nuclear Innovation and Support the Commonwealth’s Growing Energy Requirements

NANO Nuclear Energy Joins Virginia Nuclear Energy Consortium to Advance Nuclear Innovation and Support the Commonwealth’s Growing Energy Requirements

NANO Nuclear Energy Inc. (NASDAQ: NNE) has joined the Virginia Nuclear Energy Consortium (VNEC) to collaborate on advancing nuclear energy innovation, deployment, research, and workforce initiatives in Virginia, a state experiencing rapid growth in power demand, especially from data centers. As a part of VNEC, NANO Nuclear aims to leverage Virginia…

Abacus Global Management to Announce Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Abacus Global Management to Announce Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Abacus Global Management, a NYSE-listed financial services firm specializing in alternative asset management, announced it will release its Q2 2026 financial results after market close on August 6, 2026. The company will host a conference call and webcast to discuss the results the same day, providing investors with an opportunity to engage and ass…

Damora Announces Redomestication from Delaware to Cayman Islands

Damora Announces Redomestication from Delaware to Cayman Islands

Damora Therapeutics, a biotechnology company focused on treatments for blood disorders, announced its redomestication from Delaware to the Cayman Islands effective July 16, 2026. The company's shares will continue to trade on Nasdaq under the symbol DMRA with a new CUSIP. The redomestication does not change the company's operations or management.

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Amneal Pharmaceuticals has obtained FDA approval for new strengths and vial sizes of its iohexol injection, a radiographic contrast agent used in various imaging procedures. The expanded portfolio is set to meet most of the U.S. iohexol injection market demand, positioning Amneal as a key player in complex injectables and hospital products. The com…

VisionWave Files Provisional Patent Application for GhostSight™, a Hybrid Passive Radar Architecture Using Intelligent Cooperative Illumination

VisionWave Files Provisional Patent Application for GhostSight™, a Hybrid Passive Radar Architecture Using Intelligent Cooperative Illumination

VisionWave Holdings announces filing of a provisional patent application for GhostSight™, a hybrid passive radar system that combines environmental RF signals with distributed cooperative illuminators, enhanced by AI/ML fusion for improved detection, classification, and situational awareness across defense and security sectors.